Drug Shortage Report for LOVENOX HP

Last updated on 2020-04-15 History
Report ID 111405
Drug Identification Number 02242692
Brand name LOVENOX HP
Common or Proper name Lovenox HP
Company Name SANOFI-AVENTIS CANADA INC
Market Status MARKETED
Active Ingredient(s) ENOXAPARIN SODIUM
Strength(s) 120MG
Dosage form(s) SOLUTION
Route of administration SUBCUTANEOUS SUBCUTANEOUS
Packaging size 10
ATC code B01AB
ATC description ANTITHROMBOTIC AGENTS
Reason for shortage Delay in shipping of the drug.
Anticipated start date 2020-04-13
Actual start date
Estimated end date 2020-04-24
Actual end date 2020-04-14
Shortage status Resolved
Updated date 2020-04-15
Company comments The availability date represents estimated availability at the main Sanofi warehouse. Availability dates at a customer’s usual distributor warehouse may vary. Pharmacies are invited to communicate with their preferred distributor to obtain the product availability date. Patients should validate the availability of the product with their respective pharmacy.
Health Canada comments
Tier 3 Status No
Company contact information email: CAINTERNET@sanofi.com Telephone: 1-800-265-7927

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2020-04-07 English Compare
v2 2020-04-07 French Compare
v3 2020-04-14 English Compare
v4 2020-04-14 English Compare
v5 2020-04-14 French Compare
v6 2020-04-15 English Compare

Showing 1 to 6 of 6